Andreas Lundqvist
Professor
E-mail: andreas.lundqvist@ki.se
Telephone: +46852482371
Visiting address: J6:20 BioClinicum, Akademiska stråket 1, 17164 Solna
Postal address: K7 Onkologi-Patologi, K7 Forskning Lundqvist, 171 77 Stockholm
About me
- Professor, ̽»¨¾«Ñ¡, Department of Oncology-Pathology, 2023
Associate Professor, ̽»¨¾«Ñ¡, 2012
Assistant Professor, ̽»¨¾«Ñ¡, 2009
Staff Scientist, National Institutes of Health, 2008
Research fellow, National Institutes of Health, 2005
Postdoctoral fellow, National Institutes of Health, 2003
PhD, ̽»¨¾«Ñ¡, 2003
Research
- Our research focus on studies to understand how NK and T cells are regulated in patients with cancer. With this knowledge we aim to develop improved immunotherapies in patients with cancer.
Teaching
- Completed ten weeks of pedagogic training courses.
PhD course organizer: Tumor immunology and immune therapy of cancer (#3110), ̽»¨¾«Ñ¡.
More than 500 hours teaching undergradates (BSc), post-graduates (MSc and PhD) and ̽»¨¾«Ñ¡ professionals (MD).
Articles
- Article: ONCOIMMUNOLOGY. 2024;13(1):2372875
- Article: SCIENCE TRANSLATIONAL MEDICINE. 2024;16(747):eadi2952
- Article: JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH. 2024;43(1):107
- Article: JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH. 2024;43(1):13
- Article: ONCOIMMUNOLOGY. 2023;12(1):2175517
- Article: CELLS. 2023;12(17):2158
- Article: CYTOTHERAPY. 2023;25(7):763-772
- Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2023;72(5):1153-1167
- Article: CANCER IMMUNOLOGY RESEARCH. 2023;11(2):217-227
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(1):e2209856120
- Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1264012
- Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2022;10(10):e005308
- Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2022;10(6):e004458
- Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2022;10(5):e004592
- Article: NATURE CANCER. 2022;3(2):251-261
- Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2021;70(11):3155-3166
- Article: ADVANCED SCIENCE. 2021;8(21):e2101029
- Article: CANCERS. 2021;13(5):1175
- Article: EMBO REPORTS. 2021;22(3):e51329
- Article: CELLS. 2021;10(2):353
- Article: FRONTIERS IN IMMUNOLOGY. 2021;12:682627
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2020;130(10):5508-5522
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(37):22910-22919
- Article: ONCOIMMUNOLOGY. 2020;9(1):1786888
- Article: ONCOIMMUNOLOGY. 2020;9(1):1792058
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2020;130(3):1185-1198
- Article: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 2020;1296:319-348
- Article: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 2020;1231:45-51
- Article: SCIENTIFIC REPORTS. 2019;9(1):12150
- Article: METHODS IN MOLECULAR BIOLOGY. 2019;1913:197-206
- Article: METHODS IN MOLECULAR BIOLOGY. 2019;2032:105-114
- Article: CANCER IMMUNOLOGY RESEARCH. 2018;6(11):1417-1425
- Article: LAB ON A CHIP. 2018;18(16):2466-2476
- Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2017;66(10):1333-1344
- Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2017;5(1):73
- Article: ONCOIMMUNOLOGY. 2017;6(8):e1338238
- Article: ONCOTARGET. 2017;8(13):21539-21553
- Article: BLOOD. 2016;128(11):1475-1489
- Article: ONCOIMMUNOLOGY. 2016;5(5):e1128613
- Article: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2016;12(3):607-611
- Article: ONCOIMMUNOLOGY. 2016;5(1):e1052213
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2015;45(6):1783-1793
- Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2015;64(2):225-235
- Article: PLOS ONE. 2015;10(10):e0139809
- Article: CLINICAL CANCER RESEARCH. 2014;20(22):5733-5744
- Article: CLINICAL CANCER RESEARCH. 2014;20(15):4096-4106
- Article: IMMUNOBIOLOGY. 2014;219(3):189-197
- Article: JOURNAL OF IMMUNOLOGY. 2014;192(3):1313-1319
- Article: JOURNAL OF IMMUNOLOGY. 2013;191(12):6241-6249
- Article: INTERNATIONAL JOURNAL OF CANCER. 2013;133(7):1643-1652
- Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2013;62(8):1359-1368
- Article: CANCER RESEARCH. 2013;73(13):3877-3887
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2013;43(1):249-257
- Article: JOURNAL OF IMMUNOLOGY. 2012;188(5):2136-2145
- Article: CYTOTHERAPY. 2011;13(3):269-278
- Article: JOURNAL OF CANCER. 2011;2:383-385
- Article: STEM CELLS. 2010;28(9):1465-1475
- Article: JOURNAL OF IMMUNOLOGY. 2010;184(3):1139-1142
- Article: BLOOD. 2009;113(24):6120-6127
- Article: BLOOD. 2009;113(4):875-882
- Article: CYTOTHERAPY. 2009;11(3):341-355
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2008;118(3):1099-1109
- Article: CYTOTHERAPY. 2008;10(8):775-783
- Article: BLOOD. 2007;109(8):3603-3606
- Article: CANCER RESEARCH. 2006;66(14):7317-7325
- Article: EXPERIMENTAL HEMATOLOGY. 2006;34(6):796-801
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2006;133(3):305-314
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2005;131(1):74-79
- Article: THE LANCET ONCOLOGY. 2005;6(10):809-812
- Article: IMMUNOLOGY LETTERS. 2005;100(2):113-119
- Article: JOURNAL OF IMMUNOTHERAPY. 2005;28(3):229-235
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2005;128(5):668-675
- Article: BRITISH JOURNAL OF CANCER. 2004;91(4):688-694
- Article: MEDICAL ONCOLOGY. 2004;21(1):49-52
- Article: MEDICAL ONCOLOGY. 2004;21(2):155-165
- Article: CYTOTHERAPY. 2004;6(4):363-371
- Article: JOURNAL OF IMMUNOTHERAPY. 2002;25(6):445-454
- Article: HUMAN GENE THERAPY. 2002;13(13):1541-1549
- Article: BRITISH JOURNAL OF CANCER. 2002;87(4):414-422
- Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2002;51(3):139-144
- Show more
All other publications
- Review: MED. 2024;5(11):1351-1377
- Editorial comment: NATURE REVIEWS IMMUNOLOGY. 2023;23(8):478
- Letter: CANCER COMMUNICATIONS. 2023;43(7):855-859
- Review: MOLECULAR CANCER. 2022;21(1):206
- Review: FRONTIERS IN IMMUNOLOGY. 2022;13:825979
- Editorial comment: FRONTIERS IN IMMUNOLOGY. 2021;12:718844
- Review: CANCERS. 2020;12(12):E3586-3586
- Review: PHARMACOLOGY AND THERAPEUTICS. 2020;214:107603
- Letter: NATURE MEDICINE. 2020;26(7):992-994
- Review: CANCERS. 2019;11(7):E1040-1040
- Meeting abstract: CANCER IMMUNOLOGY RESEARCH. 2018;6(9):a77
- Review: FRONTIERS IN IMMUNOLOGY. 2018;9:2159
- Corrigendum: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2017;5(1):88
- Editorial comment: CYTOMETRY. PART A : THE JOURNAL OF THE INTERNATIONAL SOCIETY FOR ANALYTICAL CYTOLOGY. 2017;92(2):98-99
- Meeting abstract: CANCER IMMUNOLOGY RESEARCH. 2016;4(1):b071
- Book chapter: DEVELOPMENTS IN T CELL BASED CANCER IMMUNOTHERAPIES: CANCER DRUG DISCOVERY AND DEVELOPMENT. 2015;p. 211-229
- Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2014;15(10):18557-18573
- Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(15):tps3118
- Review: JOURNAL OF TRANSLATIONAL MEDICINE. 2013;11:247
- Meeting abstract: CANCER RESEARCH. 2013;73:a15
- Meeting abstract: CANCER RESEARCH. 2013;73:a63
- Review: JOURNAL OF TRANSLATIONAL MEDICINE. 2012;10:205
- Editorial comment: ONCOIMMUNOLOGY. 2012;1(7):1200-1201
- Editorial comment: JOURNAL OF TRANSLATIONAL MEDICINE. 2012;10:104
- Other: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2012;61(4):587-591
- Meeting abstract: BLOOD. 2011;118(21):457-458
- Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2011;47:S331
- Editorial comment: BLOOD. 2011;117(26):6974-6975
- Letter: BLOOD. 2010;116(15):2858-2859
- Meeting abstract: CANCER RESEARCH. 2010;70:1271
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):126-127
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):9-10
- Corrigendum: JOURNAL OF CLINICAL INVESTIGATION. 2008;118(4):1584
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2008;14(2):142
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2008;14(2):43
- Meeting abstract: BLOOD. 2007;110(11):4899
- Meeting abstract: BLOOD. 2007;110(11):3277
- Meeting abstract: BLOOD. 2007;110(11):2744
- Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2007;136(6):859-860
- Meeting abstract: BLOOD. 2006;108(11):923A
- Meeting abstract: BLOOD. 2006;108(11):323
- Meeting abstract: BLOOD. 2006;108(11):2981
- Review: JOURNAL OF IMMUNOTHERAPY. 2005;28(4):281-288
- Meeting abstract: BLOOD. 2004;104(11):327B
- Meeting abstract: BLOOD. 2004;104(11):811
- Meeting abstract: BLOOD. 2004;104(11):4985
- Thesis / dissertation: 2003
- Editorial comment: TRENDS IN IMMUNOLOGY. 2002;23(3):130-135
- Review: MEDICAL ONCOLOGY. 2002;19(4):197-211
- Show more
Grants
- The Swedish Childhood Cancer Fund1 January 2024 - 31 December 2025
- Swedish Research Council1 January 2023 - 31 December 2026
- The Swedish Cancer Society1 January 2022 - 31 December 2024
- The Cancer Research Funds of Radiumhemmet1 January 2022 - 31 December 2024
Employments
- Professor, Department of Oncology-Pathology, ̽»¨¾«Ñ¡, 2023-
Degrees and Education
- Doctor Of Philosophy, Department of Oncology-Pathology, ̽»¨¾«Ñ¡, 2003